A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The Knee
Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
PF-04191834 works in animal models by inhibiting one of the enzymes, 5-lipoxygenasein which
is involved in the pathway that causes inflammation and pain. The purpose of this study is to
test how effective, safe and tolerated PF-04191834 is in patients with osteoarthritis of the
knee by itself or with naproxen, particularly to test if patients have less pain.